Ramdev’s Coronil gets approval as supporting measure in Covid management

July 24: Patanjali’s Coronil tablet has been given approval by Uttarakhand’s drug licensing authority to be used as a supporting measure in Covid-19 management without claiming cure, the Lok Sabha was informed on Friday. Minister of State for Health Bharati Pravin Pawar, in a written reply, said the Interdisciplinary Technical Review Committee (ITRC) setup by the AYUSH ministry reviewed the application submitted by the Patanjali Research Foundation Trust for “updating the AYUSH license for Divya Coronil tablet” from ‘immunity booster’ to ‘medicine for COVID-19′.

“The application titled ‘Updating AYUSH license for Divya Coronil tablet from Immunity booster to Medicine for Covid-19’ submitted by Patanjali Research Foundation Trust, Haridwar, Uttarakhand to this Ministry, was placed before the ITRC on October 27, 2020 for examination of the applications/ claims on patent and propriety (P&P) ASU&H medicines with new indications or repurposing of licensed P&P, ASU&H medicines for Covid-19,” Pawar said in her reply.